Transdermal composition

Details Transdermal composition Transdermal composition

A - Human Necessities

61

K

A61K 31/135 (2006.01) A61K 9/06 (2006.01) A61K 9/127 (2006.01)

Patent

CA 2065134

A B S T R A C T The invention concerns an anhydrous transdermal preparation comprising in a 20-100 % lyotropic liquid crystalline arrange- ment 5-15 w.% of optically active or racemic N-methyl-N- -(phenyl-2-propyl)-2-propinylamine or N-methyl-(1-(4-fluoro-phenyl)-2-propyl)-2- -propylamine or their therapeutically sui- table salts, 40-70 w.% of liquid polyoxiethylene, 10-20 w % of solid polyoxiethylene, 2-30 w.% of a nonionic surface active agent, 2-20 w.% of propyleneglycol, if desired 0.5-2 w.% of a polymer the a value of which is > 0.6, and if desired in a quantity needed to 100 w.%, other auxili- ary agents.

Affiliated with

Also associated with

Rating

Transdermal composition does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Transdermal composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transdermal composition will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1828918